Cleo Diagnostics Ltd (ASX:COV)
Australia
· Delayed Price · Currency is AUD 0.4600
-0.0150 (-3.16%)
At close: Apr 17, 2025, 4:00 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 56.54 million as of April 24, 2025. Its market cap has increased by 131.58% in one year.
Market Cap
56.54M
Enterprise Value
49.23M
Revenue
210.81K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 56.54M, an increase of 120.00%. That is a compound annual growth rate of 59.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 56.54M | 23.94% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 114.55B |
| Pro Medicus | 21.45B |
| Cochlear | 17.34B |
| Sonic Healthcare | 12.02B |
| Telix Pharmaceuticals | 9.57B |
| Ramsay Health Care | 7.54B |
| Ansell | 4.14B |
| Mesoblast | 2.06B |